Evotec names Dr. Joanna Holbrook as Chief Scientific Officer
The appointment to Evotec's Management Board takes effect November 1, 2026, bringing in a 25-year industry veteran to oversee scientific strategy.
SEC filing
4 stories
The appointment to Evotec's Management Board takes effect November 1, 2026, bringing in a 25-year industry veteran to oversee scientific strategy.
SEC filing
The company reaffirmed full-year 2026 guidance while reporting preliminary revenue and EBITDA figures for the first nine months that it said topped consensus.
SEC filing
Evotec SE said Dr. Cord Dohrmann will leave his role by mutual consent, with a search underway for his successor.
SEC filing
JST-018, developed for the U.S. Department of War's Accelerated Antibodies Program, moves into first-in-human testing after manufacturing at Evotec's Redmond facility.
SEC filing